Ownership history in Commodore Capital LP · 19 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,200,000 | -1,675,000 | -34.4% | 3.37% | $69.1M | $21.58 |
| 2025 Q2 | ADDED | 4,875,000 | +1,275,000 | +35.4% | 4.81% | $68.2M | $13.98 |
| 2025 Q1 | ADDED | 3,600,000 | +1,200,000 | +50.0% | 3.58% | $48.5M | $13.48 |
| 2024 Q4 | REDUCED | 2,400,000 | -150,124 | -5.9% | 3.37% | $46.0M | $19.17 |
| 2024 Q3 | ADDED | 2,550,124 | +22,092 | +0.9% | 3.63% | $58.0M | $22.75 |
| 2024 Q2 | ADDED | 2,528,032 | +593,379 | +30.7% | 2.25% | $32.9M | $13.01 |
| 2024 Q1 | ADDED | 1,934,653 | +10,579 | +0.5% | 2.27% | $33.9M | $17.51 |
| 2023 Q4 | REDUCED | 1,924,074 | -275,926 | -12.5% | 3.63% | $41.9M | $21.78 |
| 2023 Q3 | UNCHANGED | 2,200,000 | — | 0% | 3.94% | $33.7M | $15.34 |
| 2023 Q2 | ADDED | 2,200,000 | +10,341 | +0.5% | 5.88% | $52.3M | $23.79 |
As of 2025 Q4 — sorted by position size